In order to evaluate the signaling pathways involved in GPR40 activation, Neuro2a (murine neuroblastoma) cells were treated with GPR40 synthetic ligands for 1–24 h (Fig. 3A). The gene discussed is FFAR1; the disease is neuroblastoma.